Acurx Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACXP and other ETFs, options, and stocks.About ACXP
Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme.
CEODavid P. Luci
CEODavid P. Luci
Employees4
Employees4
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2017
Founded2017
Employees4
Employees4
ACXP Key Statistics
Market cap7.26M
Market cap7.26M
Price-Earnings ratio-0.41
Price-Earnings ratio-0.41
Dividend yield—
Dividend yield—
Average volume42.25K
Average volume42.25K
High today$3.53
High today$3.53
Low today$3.45
Low today$3.45
Open price$3.50
Open price$3.50
Volume11.80K
Volume11.80K
52 Week high$25.00
52 Week high$25.00
52 Week low$3.17
52 Week low$3.17
Stock Snapshot
With a market cap of 7.26M, Acurx Pharmaceuticals(ACXP) trades at $3.46. The stock has a price-to-earnings ratio of -0.41.
On 2025-12-26, Acurx Pharmaceuticals(ACXP) stock traded between a low of $3.45 and a high of $3.53. Shares are currently priced at $3.46, which is +0.3% above the low and -2.0% below the high.
The Acurx Pharmaceuticals(ACXP)'s current trading volume is 11.8K, compared to an average daily volume of 42.25K.
During the past year, Acurx Pharmaceuticals(ACXP) stock moved between $3.17 at its lowest and $25.00 at its peak.
During the past year, Acurx Pharmaceuticals(ACXP) stock moved between $3.17 at its lowest and $25.00 at its peak.
People also own
Based on the portfolios of people who own ACXP. This list is generated using Robinhood data, and it’s not a recommendation.